drugset / Trial / NCT00927641

HKT-500 in the Treatment of Adult Patients With Ankle Sprain

NCT00927641

Phase 3 Completed 240 enrolled Hisamitsu Pharmaceutical Co., Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study is to demonstrate the multiple-dose efficacy and safety of HKT-500 for the treatment of ankle sprain.

Timeline

Start
2009-07
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketoprofen Small molecule Topical

Indications

No indication recorded.